Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-30

Clinical Trial Update: Oral Omadacycline vs. Placebo in Adults With NTM Pulmonary Disease Caused by Mycobacterium Abscessus Complex (MABc) [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing oral omadacycline to placebo in adults with nontuberculous mycobacterial pulmonary disease caused by the Mycobacterium abscessus compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nuzyra (Omadacycline)

Snippet

Sponsor: Paratek Pharmaceuticals Inc | Conditions: Mycobacterium Infections, Nontuberculous, Mycobacterium Abscessus Infection | Phase 2 | Status: COMPLETED | Results posted: 2025-07-30